We are live on
!
Find out more
Iovance Biotherapeutics
IOVA
IOVA
80 hedge funds and large institutions have $198M invested in Iovance Biotherapeutics in 2015 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 36 increasing their positions, 18 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 18
8% less call options, than puts
Call options by funds: $495K | Put options by funds: $538K
7% less funds holding
Funds holding: 86 → 80 (-6)
31% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 16
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
39% less capital invested
Capital invested by funds: $325M → $198M (-$128M)
Holders
80
Holders Change
-6
Holders Change %
-6.98%
% of All Funds
2.23%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
11
Increased
36
Reduced
18
Closed
16
Calls
$495K
Puts
$538K
Net Calls
-$43K
Net Calls Change
+$770K
Top Buyers
| 1 |
RIM
RS Investment Management
San Francisco,
California
|
+$5.22M |
| 2 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$3.34M |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$2.82M |
| 4 |
BC
Broadfin Capital
New York
|
+$2.28M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
+$2.01M |
Top Sellers
| 1 |
TCP
Tourbillon Capital Partners
New York
|
-$6.96M |
| 2 |
Boston Partners
Boston,
Massachusetts
|
-$2.31M |
| 3 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$1.97M |
| 4 |
PP
PDT Partners
New York
|
-$631K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$585K |
